Tevogen Bio Holdings Inc.
TVGN
$0.39
-$0.02-4.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.58% | -61.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.23% | -47.43% | |||
| Operating Income | -5.23% | 47.43% | |||
| Income Before Tax | -4.05% | 46.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.05% | 46.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.05% | 46.91% | |||
| EBIT | -5.23% | 47.43% | |||
| EBITDA | -7.02% | 48.11% | |||
| EPS Basic | 2.29% | 53.00% | |||
| Normalized Basic EPS | 2.14% | 53.37% | |||
| EPS Diluted | 2.29% | 56.29% | |||
| Normalized Diluted EPS | 2.14% | 53.37% | |||
| Average Basic Shares Outstanding | 6.36% | 14.19% | |||
| Average Diluted Shares Outstanding | 6.36% | 14.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||